Biophytis S.A.
ALBPS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.01 | 0.05 |
| FCF Yield | -438.44% | -472.97% | -240.65% | -41.34% |
| EV / EBITDA | -1.42 | -0.40 | -0.45 | -1.96 |
| Quality | ||||
| ROIC | -2,242.74% | -285.79% | -155.56% | -114.33% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.83 | 0.76 | 0.78 | 0.76 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 33.99% | 31.55% | 20.75% | -139.52% |
| Safety | ||||
| Net Debt / EBITDA | -1.18 | -0.20 | -0.14 | 0.24 |
| Interest Coverage | -9.75 | -11.46 | -14.57 | -6.05 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.31 | -0.44 |
| Cash Conversion Cycle | 0.00 | -2,450.91 | -4,046.67 | -9,758.76 |